Search results for #UrothelialCancer
May is #BladderCancerAwarenessMonth 📣 @drenriquegrande discusses implications of the findings from the EV-302 trial (NCT04223856) of #enfortumab vedotin, an #ADC & #pembrolizumab in patients with locally advanced or metastatic #urothelialcancer 🔦 👉 ow.ly/iIuk50Rsive
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer @Markuseckstein3 @JCO_ASCO #Oncology #urothelialCancer #MedEd #MedX #Cancer #enfortumab ascopubs.org/doi/10.1200/JC…
.@DrScottTagawa spoke with @OncLive about the reasons for investigating nivolumab plus cisplatin-based #chemotherapy as a first-line treatment for #UrothelialCancer: bit.ly/3W54mcW
#Clinicaltrial EA8192 aims to find out if treatment with durvalumab and chemotherapy can improve outcomes for patients with high grade upper tract #urothelialcancer prior to nephroureterectomy. bit.ly/ea8192-trial #blcsm #bladdercancer cc: @JCensits, @PGrivasMDPhD
Role of Chemoablation Using UGN-101 in Upper Tract Urothelial Carcinoma: A Systematic Review and MetaAnalysis of Available Evidence @AbdallaDeb et al. #urothelialcancer #chemoablation #mitomycin #metaanalysis Link : urologyresearchandpractice.org/en/role-of-che…
A class on advanced urothelial cancer, still with doubts about the application of the EV 302 studies, published in 2023. BRAZIL still without approval in the first line for platinum-eligible patients. Excited for better outcomes and implementation!! #Urothelialcancer #ESMO
Watch all WND GU videos 👉 bit.ly/3P3eDSI #MediMix #GUCancer #BladderCancer #oncologyInnovation #urology #oncology #FGFRalt #urothelialcancer
It was known that immune checkpoint inhibitors (#ICI) are highly effective in #UrothelialCancer, but the influence of the #tumor microenvironment (#TME) was always unclear 🧠 Until now. See the exciting research by @NKI_nl ⬇️ x.com/nki_nl/status/… #cancer #cancerresearch
It was known that immune checkpoint inhibitors (#ICI) are highly effective in #UrothelialCancer, but the influence of the #tumor microenvironment (#TME) was always unclear 🧠 Until now. See the exciting research by @NKI_nl ⬇️ x.com/nki_nl/status/… #cancer #cancerresearch
Don't miss the new @OncLive interview with @WCMEnglanderIPM's Dr. Scott T. Tagawa (@DrScottTagawa) on "The Rationale for Investigating First-Line #Nivolumab Plus #Cisplatin in #UrothelialCancer. #PrecisionMedicine onclive.com/view/dr-tagawa…
Amazing to see our first patient enrolled on EV-302 still in complete remission after 3 years - @shilpaonc oncodaily.com/50109.html #Cancer #OncoDaily #Oncology #UrothelialCancer
EV-302: Enfortumab vedotin + pembrolizumab outperforms chemo in untreated advanced #UrothelialCancer. @MichvdHeijden @NKI_nl joins @UroCancerMD @VUMCurology to discuss the trial's structure and its remarkable findings. #WatchNow > bit.ly/4aKRrl3
Happy to share our comprehensive review on adjuvant treatment of muscle-invasive urothelial cancer - @shilpaonc @ClevelandClinic #Cancer #UrothelialCancer #OncoDaily #Oncology #Clinicaltrials oncodaily.com/46024.html
👀 Up next at #EAU24: The session on advancing #UrothelialCancer care begins at 10:30 a.m. Chairs: 🎙️ Dr. Simon Crabb 🎙️ Dr. Tianxin Lin 🎙️ @SiaLindskrog @Uroweb
Did you miss our last roundtable on #ProstateCancer and #UrothelialCancer? Catch the free, full discussion on the latest treatment advances across both indications with @AOmlin, @dmukherji and @AlisonBirtle online. Here's a snippet on @AlisonBirtle's key messages ⬇️
What every urologist should know about UGN-101 treatment and its real-world implications for #UrothelialCancer. Hristos Kaimakliotis, MD @IUMedSchool joins @UroCancerMD to discuss findings focusing on real-world practices with @jelmyto > bit.ly/4a4Au4Q @UroGenPharma
#TumorBoardTuesday 🏹We are taking aim at true targeted therapy this week🎯💊 📢Join us Tuesday, 04.02.2024 at 8PM ET as @sonpavde & @JonAnker1🗣️tailoring Tx in metastatic #urothelialcancer with FGFR🎯💊 RT and bring others into the discussion‼️
